Medicine
Bromocriptine 2.5 mg tablet
Bromocriptine 2.5 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F) Dispense in a tight, light-resistant…
Key facts
- Active ingredient (INN)
- Bromocriptine
- Brand
- Sold under the generic name
- Strength
- 2.5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets, 30 blister pack and 5 more
- Manufacturers
- ANI PharmaceuticalsPadagisSandozAmerican Health PackagingRemedyrepack
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F) Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G02CB01 Bromocriptine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 January 1998
- Identifiers
- RxCUI 197411, 197412DailyMed set ID 0ee2da00-faf8-4c51-a696-9462fa4f6050, c43c300d-8aec-4020-984a-42c1a917c08f, 17f3a343-1782-4799-95ba-31dfe93be2cf +2NDC 0574-0106, 0781-5325, 70954-978 +2Application ANDA077646, ANDA074631, NDA017962
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 70954-978-10 | ANI Pharmaceuticals | 15 June 2025 |
| 100 tablet in 1 bottle | 70954-978-20 | ANI Pharmaceuticals | 15 June 2025 |
| 100 tablet in 1 bottle, plastic | 0574-0106-01 | Padagis | 1 April 2014 |
| 30 tablet in 1 bottle, plastic | 0574-0106-03 | Padagis | 1 April 2014 |
| 100 tablet in 1 bottle | 0781-5325-01 | Sandoz | 13 January 1998 |
| 30 tablet in 1 bottle | 0781-5325-31 | Sandoz | 13 January 1998 |
| 30 blister pack in 1 carton / 1 tablet in 1 blister pack | 60687-931-21 | American Health Packaging | 12 June 2026 |
| 50 pouch in 1 box / 1 tablet in 1 pouch | 70518-4628-0 | Remedyrepack | 24 April 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 June 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Bromocriptine
Clinical summary
Bromocriptine is an ergot derivative indicated for the treatment of hyperprolactinemia-associated dysfunction including amenorrhea with or without galactorrhea, infertility, or hypogonadism in adults, among other approved uses. It is available as tablets and capsules for oral use. MedsAcross supplies Bromocriptine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BromocriptineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Bromocriptine Mesylate prescribing information (ANI Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Bromocriptine 2.5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.